- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04707599
Telephone Reminder to Increase Appointment Rates
Reducing the Rate of Missed Appointments in an Outpatient Substance Use Treatment Clinic in Norway
Missed appointments to outpatient substance use treatment are common and costly and can have a negative effect on the health of patients.
In this quasi-experimental study, the investigators used an on-off design to examine whether a reminder "plus" intervention (telephone call from therapist before first appointment) would increase attendance and improve cancellation and rebooking practices. Secondary outcomes included satisfaction with treatment and intention to complete the treatment program.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Agder
-
Arendal, Agder, Norway
- Addiction Unit - Sørlandet Hospital
-
Kristiansand, Agder, Norway, 4600
- Addiction Unit - Sørlandet Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Newly referred patient
- > 18 years
- Diagnosis: Substance related disorder
Exclusion Criteria:
- Patients who are unable to understand or score the survey due to cognitive or language barriers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: OFF intervention
No reminder plus (telephone reminder from therapist) but standard test message reminder (SMS) from second admission
|
|
Experimental: ON intervention
Reminder plus (telephone reminder from therapist) AND standard test message reminder (SMS) from second admission
|
Reminder plus (telephone call from therapist)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attendance rate
Time Frame: Up to 10 treatment sessions, estimated average timeframe = 3 months
|
Attendance rate at first admission and during 10 outpatient sessions
|
Up to 10 treatment sessions, estimated average timeframe = 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dropout rate
Time Frame: Up to 10 treatment sessions, estimated average timeframe = 3 months
|
Dropout rate within 10 sessions - measured as formal discharge and/or "technical discharge" (3x no-shows)
|
Up to 10 treatment sessions, estimated average timeframe = 3 months
|
Cancellation / rebooking rate
Time Frame: Up to 10 treatment sessions, estimated average timeframe = 3 months
|
Examine difference in cancellation / rebooking rate between the two conditions.
Data was collected from administrative patient records.
|
Up to 10 treatment sessions, estimated average timeframe = 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment satisfaction
Time Frame: First week
|
Treatment satisfaction - measured with the Session Rating Scale (scale 0 - 40, higher scores means higher satisfaction)
|
First week
|
Intention to complete treatment
Time Frame: First week
|
Intention to complete treatment program.
Self-developed measured based on the Theory of Planned Behavior.
Scale 1 - 7, higher scores means higher intention to Complete treatment).
|
First week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John-Kåre Vederhus, PhD, Sørlandet Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 005004 - 2014/2225
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentRecruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA)Completed
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
Clinical Trials on Reminder plus (telephone call from therapist)
-
Norwegian Institute of Public HealthNot yet recruitingCancer Colorectal
-
Imperial College LondonCompletedSleep Apnea Syndromes | Asthma | Tuberculosis | COPDUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Wills EyeCompleted
-
Mayo ClinicWithdrawnColorectal (Colon or Rectal) CancerUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCardiorespiratory FailureUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)CompletedOvarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Vaginal Cancer | Peritoneal Cancer | Uterine CancerUnited States